ASCO 2017

Precision Oncology Drug Shows Power Of Cancer Genomics
Forbes
Fri, 06/9/17 - 09:59 am
cancer genomics
Loxo Oncology
LOXO-101
ASCO 2017
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
Wed, 06/7/17 - 10:11 am
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
ASCO17: Juno marks progress with second-gen CAR-T
BioPharma Dive
Tue, 06/6/17 - 12:16 pm
ASCO 2017
Juno Therapeutics
CAR-T
JCAR017
non-Hodgkin's lymphoma
JCAR015
ASCO dark horse Nanjing Legend Biotech shines with promising CAR-T data
Fierce Biotech
Tue, 06/6/17 - 10:41 am
ASCO 2017
Nanjing Legend Biotech
CAR-T
LCAR-B38M
ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge
Fierce Pharma
Tue, 06/6/17 - 09:55 am
ASCO 2017
Dendreon
prostate cancer
Provenge
vaccines
ASCO17: AstraZeneca pumps up expectations on near-term cancer drug wins, looking to shed a rep for failure
Endpoints
Tue, 06/6/17 - 09:44 am
AstraZeneca
ASCO 2017
Lynparza
breast cancer
Pfizer's $14B Medivation deal's now a cautionary M&A tale, thanks to ASCO: analyst
Fierce Pharma
Tue, 06/6/17 - 09:41 am
Pfizer
Medivation
M&A
ASCO 2017
ASCO17: Merck touts Keytruda bladder benefit post Tecentriq failure
BioPharma Dive
Mon, 06/5/17 - 12:13 pm
Merck
Keytruda
bladder cancer
Tecentriq
ASCO 2017
ASCO17: Roche's Alecensa bests Xalkori in lung study
BioPharma Dive
Mon, 06/5/17 - 12:11 pm
Roche
Alecensa
Xalkori
ASCO 2017
Pfizer
lung cancer
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Endpoints
Mon, 06/5/17 - 12:10 pm
Bluebird Bio
BCMA
CAR-T
Multiple Myeloma
ASCO 2017
bb2121
Celgene
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Fierce Pharma
Mon, 06/5/17 - 12:08 pm
Takeda
Roche
ALK inhibitors
ASCO 2017
lung cancer
Kite Pharma's ASCO ads aim to prep docs on CAR-T ahead of FDA approval
Fierce Pharma
Mon, 06/5/17 - 12:06 pm
Kite Pharma
CAR-T
FDA
ASCO 2017
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Endpoints
Mon, 06/5/17 - 10:08 am
Incyte
ASCO 2017
epacadostat
non-small cell lung cancer
Keytruda
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
Forbes
Sun, 06/4/17 - 11:53 am
AstraZeneca
Lynparza
breast cancer
BRCA-mutant breast cancer
ASCO 2017
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Sun, 06/4/17 - 11:51 am
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Early use of J&J's Zytiga extends prostate cancer survival
Yahoo/Reuters
Sun, 06/4/17 - 11:46 am
JNJ
Zytiga
prostate cancer
ASCO 2017
Facts & Figures: Diversity in Oncology
ASCO.org
Sat, 06/3/17 - 09:26 am
diversity
physicians
oncology
ASCO 2017
J&J's Zytiga slashes death risk by 38% in earlier-stage prostate cancer patients
Fierce Pharma
Sat, 06/3/17 - 09:23 am
JNJ
Zytiga
prostate cancer
ASCO 2017
Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval
Endpoints
Sat, 06/3/17 - 09:21 am
Loxo Oncology
ASCO 2017
biomarkers
LOXO-101
larotrectinib
At big cancer meeting, a big question: Is the U.S. ‘losing its edge’
Stat
Fri, 06/2/17 - 11:38 am
ASCO 2017
oncology

Pages